“Clinicopathologic Characteristics, Pathological Response and Safety Profile of Triple-Negative Breast Cancer (TNBC) Patients: A Retrospective Study in Yogyakarta” (2026) Duta Pharma Journal, 6(1), pp. 114–120. doi:10.47701/hy4h0v48.